Korro Bio Inc (NAS:KRRO)
$ 13.24 +1.07 (+8.78%) Market Cap: 195.04 Mil Enterprise Value: 122.22 Mil PE Ratio: 0 PB Ratio: 2.26 GF Score: 6/100

Korro Bio Inc Analyst Day Transcript

Jan 27, 2026 / 01:00 PM GMT
Release Date Price: $10.74 (+0.09%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KRRO.OQ - Korro Bio Inc
Korro Bio Inc Analyst Day
Jan 27, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
How to handicap, the variables that would be predictive of editing efficiency in humans once we get to the clinical trial.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
And we'll continue with like on this.

--------------------------------------------------------------------------------
Unidentified_3 [3]
--------------------------------------------------------------------------------
One. Yeah, so I mean if you compareer A1 and citizens, there are fundamentally different targets. For the earlier you TRY to correct a mist mutation. For the later, you TRY to improve the function,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot